CPHI vs LLY · rev $4.1M vs P/E 39, rev $65.18B
China Pharma Holdings Inc (CPHI) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CPHI currently screens at market cap $29.0M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CPHI and LLY stock pages for the full models.
Not investment advice.